MaaT Pharma S.A.

MAAT.PA · PAR
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-€29-€20-€14-€9
Dep. & Amort.€2€1€0€0
Deferred Tax€0-€1€0€0
Stock-Based Comp.€2€1€1€1
Change in WC€3-€0-€0-€0
Other Non-Cash€0€0€0€0
Operating Cash Flow-€22-€19-€13-€8
Investing Activities
PP&E Inv.-€1-€1-€1-€0
Net Acquisitions€0€0€0€0
Inv. Purchases-€0€0-€0€0
Inv. Sales/Matur.€0€0€0€0
Other Inv. Act.€0€1€0€0
Investing Cash Flow-€0-€0-€1-€0
Financing Activities
Debt Repay.€2-€4€6-€0
Stock Issued€17€13€0€32
Stock Repurch.€0-€0-€0€0
Dividends Paid€0€0€0€0
Other Fin. Act.-€0-€0-€0-€0
Financing Cash Flow€18€8€5€32
Forex Effect€0€0-€0€0
Net Chg. in Cash-€4-€11-€8€23
Supplemental Information
Beg. Cash€24€35€43€20
End Cash€20€24€35€43
Free Cash Flow-€23-€20-€13-€8
MaaT Pharma S.A. (MAAT.PA) Financial Statements & Key Stats | AlphaPilot